Generate a tailored SOP for Dr. Peter Larsson. Improve your application with a focused, well-structured draft.
Peter Larsson is a postdoctoral researcher at the University of Gothenburg, focusing on oncology. His doctoral thesis, which he defended in June 2023, centered on proteasome target cancer therapy. Larsson's work includes significant contributions to understanding cancer treatments, particularly in exploring the potential of pan-cyclin-dependent kinase inhibition for treating adenoid cystic carcinoma. His research employs multi-omics analysis to identify drug repurposing opportunities for cancers affecting the kidney, nervous system, and hematological systems. Larsson has authored and co-authored several publications, contributing to key findings in cancer communications and scientific reports, specifically dealing with stem cell prevalence in triple-negative breast cancer and the identification of prognostic biomarkers. His expertise lies at the intersection of molecular biology and oncology, with a keen interest in drug sensitivity and treatment optimization in various cancer subtypes.
Administered by the Department of Political Science; focus on International Administration and Global Governance (IAGG).